Efficacy and Safety of Triple Combination Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Patients With Cystic Fibrosis: A Meta-Analysis of Randomized Controlled Trials

Background: Cystic fibrosis is a rare, recessive, progressive genetic disease caused by dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Small molecules have recently been developed to treat the molecular consequences of CFTR mutations and restore CFTR protein f...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Yizi Wang, Bin Ma, Wenya Li, Peiwen Li
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2022-03-01
Ráidu:	Frontiers in Pharmacology
Fáttát:	cystic fibrosis transmembrane conductance regulator cystic fibrosis CFTR corrector potentiator
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fphar.2022.863280/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!